A New Era in the
Prevention and Management of CMV Infection
A continuing medical
education activity sponsored by NAMCP and AAMCN
This webinar series will provide critical updates on the advances in
the management of CMV
These are archives of live webinars held between July 23, 2021 to
July 28, 2021
If you participated in any of the live webinars, you are not
eligible to claim credit from the archive of that webinar.
By clicking on each of the titles, you will be able to participate
in each part.
It is not required that you participate in all three or in order.
These activities are valid from September 1, 2021 to September 1,
series is supported by an educational grant from
This activity is intended for healthcare professionals practicing in managed
Instructions for CME/NCPD: Complete the pre-test,
listen to the audio and view the slides, complete the post test, complete the
evaluation form and hit submit. You will be asked to enter your name and email
address on the pre-test, evaluation and post-test. If you close your internet
browser without completing the post test, you will have ONE more opportunity to
complete. A score of 70% must be achieved on the post test to receive continuing
education credits. If you do not pass the post test after two attempts, you will
not be eligible to try again. Once you complete the evaluation form and score
70% or higher on your post test, you will automatically be given your
Cytomegalovirus (CMV) infection remains a frequent complication in hematopoietic
stem cell transplantation (HSCT) and solid organ transplantation (SOT)
recipients. In addition to causing a variety of end-organ diseases, CMV
infection is also associated with rejection after SOT and with graft versus host
disease (GVHD) after HSCT. Antiviral prophylaxis is effective against direct and
indirect effects of CMV infection. Preemptive therapy, more commonly used after
HSCT, is based on surveillance, and targets therapy to patients at highest risk.
Novel antiviral therapies with different mechanisms of action have recently
become available giving healthcare professionals new options in the management
of this infection. This program will take a look at those advances and provide
up to date strategies for the management of CMV infection.
This webinar series on the evolving role of novel therapies in CMV infection
management will take a close look at recent guideline updates, clinical data,
and strategies for the prevention and management of CMV.